Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Post-Treatment Reactions to Ivermectin vs DEC in Loa Loa Infection
NCT01593722Phase 4Completed
- Sponsor
- National Institute of Allergy and Infectious Diseases
- Start
- Apr 2012
- Primary completion
- Aug 2013
- Modality
- Classical Binding Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of ivermectin, diethylcarbamazine in loiasis, sponsored by National Institute of Allergy and Infectious Diseases. Started Apr 2012; status: completed.
02
Drugs
ivermectindiethylcarbamazine
03
Conditions
loiasis
Beyond the preview
Go deeper on NCT01593722.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01593722.